Drugs.com - New Drug Approvals

FDA Approves Tryptyr (acoltremon) Ophthalmic Solution for the Treatment of Dry Eye Disease

GENEVA--(BUSINESS WIRE) May 28, 2025 -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. Food and Drug Administration (FDA) has approved Tryptyr® (acoltremon ophthalmic...

May 29, 2025 - 02:50
 0
FDA Approves Tryptyr (acoltremon) Ophthalmic Solution for the Treatment of Dry Eye Disease
GENEVA--(BUSINESS WIRE) May 28, 2025 -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. Food and Drug Administration (FDA) has approved Tryptyr® (acoltremon ophthalmic...
Read More

Tags:

Previous Article

VinFast showcases the VF 6 right-hand drive for the first time at IIMS Surabaya ...

Next Article

We Have Failed Science in the USA

Related Posts

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Inte...

May 27, 2025  0

Mirum’s Livmarli Now FDA Approved in Tablet Formulation

May 12, 2025  0

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) a...

May 12, 2025  0